Your browser doesn't support javascript.
loading
Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk.
Zhou, Jian; Park, Christopher Y; Theesfeld, Chandra L; Wong, Aaron K; Yuan, Yuan; Scheckel, Claudia; Fak, John J; Funk, Julien; Yao, Kevin; Tajima, Yoko; Packer, Alan; Darnell, Robert B; Troyanskaya, Olga G.
Affiliation
  • Zhou J; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
  • Park CY; Graduate Program in Quantitative and Computational Biology, Princeton University, Princeton, NJ, USA.
  • Theesfeld CL; Flatiron Institute, Simons Foundation, New York, NY, USA.
  • Wong AK; Flatiron Institute, Simons Foundation, New York, NY, USA.
  • Yuan Y; Laboratory of Molecular Neuro-Oncology and Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
  • Scheckel C; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
  • Fak JJ; Flatiron Institute, Simons Foundation, New York, NY, USA.
  • Funk J; Laboratory of Molecular Neuro-Oncology and Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
  • Yao K; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Tajima Y; Laboratory of Molecular Neuro-Oncology and Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
  • Packer A; Institute of Neuropathology, University of Zurich, Zurich, Switzerland.
  • Darnell RB; Laboratory of Molecular Neuro-Oncology and Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
  • Troyanskaya OG; Flatiron Institute, Simons Foundation, New York, NY, USA.
Nat Genet ; 51(6): 973-980, 2019 06.
Article in En | MEDLINE | ID: mdl-31133750
ABSTRACT
We address the challenge of detecting the contribution of noncoding mutations to disease with a deep-learning-based framework that predicts the specific regulatory effects and the deleterious impact of genetic variants. Applying this framework to 1,790 autism spectrum disorder (ASD) simplex families reveals a role in disease for noncoding mutations-ASD probands harbor both transcriptional- and post-transcriptional-regulation-disrupting de novo mutations of significantly higher functional impact than those in unaffected siblings. Further analysis suggests involvement of noncoding mutations in synaptic transmission and neuronal development and, taken together with previous studies, reveals a convergent genetic landscape of coding and noncoding mutations in ASD. We demonstrate that sequences carrying prioritized mutations identified in probands possess allele-specific regulatory activity, and we highlight a link between noncoding mutations and heterogeneity in the IQ of ASD probands. Our predictive genomics framework illuminates the role of noncoding mutations in ASD and prioritizes mutations with high impact for further study, and is broadly applicable to complex human diseases.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Human / Genetic Predisposition to Disease / RNA, Untranslated / Genomics / Autism Spectrum Disorder / Deep Learning / Mutation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Human / Genetic Predisposition to Disease / RNA, Untranslated / Genomics / Autism Spectrum Disorder / Deep Learning / Mutation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: United States